Brainstorm Cell Therapeutics’ $7.5 Million Common Stock Direct Offering

Goodwin advised BrainStorm on the offering, and Ellenoff Grossman advised the placement agent.BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) announced its registered direct offering of 4,054,055 shares…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now